The role of atypical antipsychotics in bipolar depression and anxiety disorders (Q28236713)

The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders?

Europe PubMed Central

title

The role of atypical antipsychotics in bipolar depression and anxiety disorders (English)

0 references

1 reference

Roger McIntyre

1

0 references

Martin Katzman

series ordinal

2

0 references

language of work or name

English

0 references

publication date

2003

0 references

published in

Bipolar Disorders

0 references

volume

5 Suppl 2

0 references

page(s)

20-35

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Bipolar II disorder: symptoms, course, and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Excess mortality in bipolar and unipolar disorder in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Excess mortality in depression: a meta-analysis of community studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Minor and major depression and the risk of death in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Anxiety as a correlate of response to the acute treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

The relationship between anxiety and substance use disorders among individuals with severe affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Anxious and non-anxious bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community-based longitudinal investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Antidepressant-associated mania: a study of anxiety disorders patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Bipolar depression: pharmacotherapy and related therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Role of risperidone in bipolar II: an open 6-month study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine as long-term adjunctive therapy in treatment-resistant bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine versus divalproex in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Obesity as a correlate of outcome in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine treatment for post-traumatic stress disorder: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Cross-national epidemiology of major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Attempted Suicide and Alcoholism in Bipolar Disorder: Clinical and Familial Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Bipolar II disorder and comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

The emerging epidemiology of hypomania and bipolar II disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Depressive mania associated with nonresponse to antimanic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Differences and similarities in mixed and pure mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Comorbidity of anxiety disorder among patients with bipolar I disorder in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Parsing the comorbidity between bipolar disorder and anxiety disorders: a familial risk analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Combining cognitive testing and informant report to increase accuracy in screening for dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

A history of substance abuse complicates remission from acute mania in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Clinical predictors of acute response with quetiapine in psychotic mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Selective serotonin reuptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Risperidone in the treatment of acute stress disorder in physically traumatized in‐patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X

Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-2406.2003.00061.X